Abstract
Background
HBA1c is used as an indicator for the long-term control of the glycaemic state and outcome predictors in diabetic patients. Diabetic patients have an increased risk of post-operative complications especially those related to infection. The aim of our study is to ascertain the relationship between HBA1c levels and post-operative recovery within the subspecialty of gynaecological oncology.
Method
Prospective cohort study during the period 1 August 2012 through 31 August 2014. Preoperative measurement of HBA1c on all gynaecological oncology patients that underwent major surgery. Patient variables collected and analysed were BMI (kg/m2), length of stay (LOS in days), cancer stage (stage 1 through stage 4), infective complications, non-infective complications and readmission to hospital.
Results
A total of 300 patients were included in our study, 34 of them were known to be diabetic while 266 were presumed to be non-diabetic. Of the presumed non-diabetic cohort, 17.3 % (46/266) had impaired glucose tolerance or diabetes. Mean BMI was significantly increased in the pre-existing diabetic group (32.8 vs. 29.3 kg/m2, p = 0.016). Infective complications were almost double the rate amongst the known diabetic women than those presumed to be non-diabetic (32.4 vs. 18.0 %, p = 0.048). Rate of re-admission to hospital due to complications was 20.6 % in the diabetic group and 4.1 % within the presumed non-diabetic group (p < 0.001). Infective complications occurred in 16.9 % of women with HBA1c <42 mmol/mol, 22.7 % of those with HBA1c of 42–47 mmol/mol, 43.5 % of patients with HBA1c 48–64 mmol/mol and 37.5 % of patients with HBA1c >64 mmol/mol. Non-infective complications were also more frequent in women with elevated HBA1c (11.1, 22.7, 26.1 and 12.5 % in those women with HBA1c <42, 42–47, 48–64 and >64 mmol/mol, respectively). Re-admission to hospital within 30 days for a complication of surgery occurred in 4.4 % of women with HBA1c <42 mmol/mol, 4.5 % of women with HBA1c measured at 42–47 mmol/mol, 30.8 % of those with HBA1c 48–64 mmol/mol and 25 % of women with HBA1c >64 mmol/mol.
Conclusion
Preoperative measurement of HBA1c may identify patients (both diabetic and non-diabetic women) at higher risk of postoperative complications and could be used as a trigger for modification of the perioperative management of such patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jeppsson J-O, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umwnoto M, Weykamp C (2005) Approved IFCC reference method for the measurement of HBA1c in human blood. Clin Chem Lab Med 40(1):78–89
McCullough ML, Patel AV, Patel R, Rodriguez C, Fiegelson HS, Bandere EV, Gansler T, Thun MJ, Calle EE (2008) Body mass and endometrial cancer risk in hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 17:73–79
Lindermann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2008) Body mass, diabetes and smoking, and endometrial cancer risk: a follow up study. Br J Cancer 98:1582–1585
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort. Br Med J 335:1134
Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, Das N, Desai R, Gornall R, Beardmore-Gray A, Nevin J, Hillaby K, Leeson S, Linder A, Lopes A, Meechan D, Mould T, Varkey S, Olaitan A, Rufford B, Ryan A, Shanbhag S, Thackeray A, Wood N, Reynolds K, Menon U (2015) Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC-UK gynaecological oncology surgical outcomes and complications). Br J Cancer 112(3):475–484
Raja SG, Rochon M, Jarman JW (2015) Brompton Harefield Infection Score (BHIS): development and validation of a stratification tool for predicting risk of surgical site infection after coronary artery bypass grafting. Int J Surg 16(Pt A):69–73
Dhatariya N, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, Hilton L, Jairam C, Leyden K, Lipp A, Lobo D, Sinclaire-Hammersley M, Rayman G (2012) NHS guidelines for the perioperative management of the adult patient with diabetes. Diabet Med 29:420–433
Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, Hudson M, Mendoza J, Johnson R, Lin E, Umpierrez GE (2010) Prevalence and clinical outcome of hyperglycaemia in the peripoerative period in noncardiac surgery. Diabetes Care 33(8):1783–1788
Diabetes UK (2012) State of the Nation 2012, England. Diabetes UK, London
Gustafsson UO, Thorell A, Soop M, Ljungqvist O, Nygren J (2009) Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg 96(11):1358–1364
Hudson CC, Welsby IJ, Phillips-Bute B, Mathew JP, Lutz A, Chad Hughes G, Stafford-Smith M, Cardiothoracic Anesthesiology Research Endeavors (C.A.R.E.) Group (2010) Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anaesth 57(6):565–572
O’Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, Lowery A, Sultan S (2006) Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg 32(2):188–197
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
I certify that no actual or potential conflict of interest in relation to this article exists.
Rights and permissions
About this article
Cite this article
Iavazzo, C., McComiskey, M., Datta, M. et al. Preoperative HBA1c and risk of postoperative complications in patients with gynaecological cancer. Arch Gynecol Obstet 294, 161–164 (2016). https://doi.org/10.1007/s00404-015-3983-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3983-8